Award
NIH Reporter #1R03CA303759-01
Mouse models of caspase-2 deficient nucleophosmin-mutated AML
Recipient
Not specified
Award Amount
$160,500.00
Ceiling
$160,500.00
Awarded
July 10, 2025
Identifier
1R03CA303759-01
NIH grant awarded by the National Cancer Institute for research on mouse models of caspase-2 deficient nucleophosmin-mutated AML, with funding of $160,500 for fiscal year 2025.
Description
This is a NIH grant opportunity for research on mouse models of caspase-2 deficient nucleophosmin-mutated AML, funded by the National Cancer Institute. The award amount is $160,500 for fiscal year 2025, with a project duration from July 10, 2025, to June 30, 2027. The project aims to investigate the role of caspase-2 in AML using in vivo murine models.